slide1
Download
Skip this Video
Download Presentation
World Cancer Drugs & Treatments Market Trends & Growth 2023

Loading in 2 Seconds...

play fullscreen
1 / 6

World Cancer Drugs & Treatments Market Trends & Growth 2023 - PowerPoint PPT Presentation


  • 79 Views
  • Uploaded on

Get a Sample Beochure @ http://tinyurl.com/j5zbg8e\n\nGlobal cancer drugs and treatments market will reach $143.7bn by 2023. \'The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023’ explains just how this market will experience growth over the medium and long term. The report also highlights forecast for the next 5 and 10 years, so that you and your company can make specific long term plans. Don’t let your competitors get the head-start on you, order this report today.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'World Cancer Drugs & Treatments Market Trends & Growth 2023' - daniel2a


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
slide1
The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023

Published Date : 21 November, 2013 | No of Pages: 243 Single User Price: $ 2500

“Global Cancer Drugs And Treatments Market will reach $143.7bn by 2023”

Click Here To Check Complete Report

slide2
The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023’
  • Global cancer drugs and treatments market will reach $143.7bn by 2023. 'The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023’ explains just how this market will experience growth over the medium and long term.
  • The report also highlights forecast for the next 5 and 10 years, so that you and your company can make specific long term plans.

Don’t let your competitors get the head-start on you, order this report today. 

  • Have you seen the recent news on Cancer Drugs?
  • Merck’s new cancer drug kept more than 4 of 5 melanoma patients alive for a year
  • Biopharma Alliances will be needed For Cancer Drugs in the cost conscious future – Forbes
  • EU approval for Bayer’s prostate cancer drug
  • Sanofi ditches late-stage bone marrow cancer drug
slide3
The Anti-cancer treatment market is already worth $77.4bn (GMR Data) and continues to

be one of the largest and fastest growing areas for new drug development – can you afford

not to be involved? Should you and your company be capturing a greater market share?

Essential facts examined in this report

  • Across 2013, 15 new molecular entities were approved by the FDA; out of which seven
  • were for Oncology.
  • Currently targeted therapies dominate the oncology pipeline, followed by chemotherapy.
  • Immunotherapy drugs are gaining increasing amounts of attention due to fewer expected
  • side effects.
  • Only by ordering this in-depth exclusive report will you have full access to the unique
  • findings. This information is not available anywhere else. Find full details of these approved
  • drugs alongside key cancer drugs in their testing phases in this report.

Make an Inquiry Before Buying

slide4
Discover exactly what the industry leaders are doing TODAY
  • 'The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023’ we analyse the key cancer drugs and treatments in the market currently and how they will perform across the next decade.
  • Our study focuses on the individual revenues of the top 25 anti-cancer agents. With variable patents and the threat of generics, how will these key cancer drugs fare across the next decade? – ONLY THIS UNIQUE REPORT WILL TELL YOU
  • Rituxan
  • Herceptin
  • Avastin
  • Gleevec
  • Revlimid
  • Alimta
  • Velcade
  • PLUS – In-depth country analysis – Discover which countries and regions will drive the oncology drugs market to 2023?

Download Sample Brochure

slide5
The US spent $322bn on healthcare in 2011, GMR Data estimate that the US spent $31.8bn in the oncology market in 2012, capturing 40.5% of the market.
  • 2nd to the US was Japan; spending $8.9bn in 2012, capturing 11.2%. The European mainstays of the pharmaceutical sector; the UK, Germany, France, Spain & Italy equated to 25% of the global oncology market in 2012.
  • But how will these country’s markets develop? This report will tell you - TODAY
  • Exclusive Industry sourced information, not available anywhere else
  • As well as primary and secondary research sources, GMR Data have interviewed leading cancer specialists within big pharma, R&D, wholesalers, distributors, marketeers and key clinical organisations.
  • From these interviews we have selected original, exclusive, transcribed interviews with leading specialists in their field – This information is not available anywhere else.
  • With over 240+ pages, and over 270+ charts, tables and graphs, this dedicated specialist report will ensure you remain equipped and fully informed, to succeed in this competitive market
slide6
The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023

A detailed qualitative analysis of the factors responsible for driving and restraining growth of the World Cancer Drugs & Treatments Market and future opportunities are provided in the report.

Contact:

1-302-261-5343

[email protected]

www.marketintelreports.com

Click here to order a copy of World Cancer Drugs & Treatments Market Report

ad